Ole Kristian Hjelstuen • 1962 • Oslo • 9 roles • 7 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
I INVEN2 AS	Managing Director/CEO	81,985,000	193,575,000	-

Boards

Name	Role	Total operating income	Total equity	Shares
T THE PHARMA FACTORY AS	Contact Person	-	40,614	100 % directly
A ALEAP AS	Board Member	18,644,291	2,209,759	-
K KINN TUR- OG FRITIDSFISKEFORENING	Contact Person	-	-	-
O OSLO CANCER CLUSTER INCUBATOR AS	Board Member	21,072,272	8,634,534	-
I IMMUNOQUEST THERAPEUTICS AS	Chairman	-	30,000	-
N NEWCO INVEN2 IV AS	Chairman	-	-	-

Last update: Aug 23, 2024

Related industries3

Professional, scientific and technical activities
Other service activities
Real estate activities

Direct relationships5

KW
Ketil Forsland Widerberg1977
OSLO CANCER CLUSTER INCUBATOR AS
BE
Benedicte Elisabeth Bakke Agerup1964
INVEN2 AS
TE
Tom Edward Pike1960
INVEN2 AS
AP
Anders Pablo Kapstad1964
IMMUNOQUEST THERAPEUTICS AS
PM
Per Morten Sandset1956
INVEN2 AS

Shares owned by Ole Kristian Hjelstuen

Name	Share class	Total operating income	Total equity	Share
T THE PHARMA FACTORY AS	Ordinære aksjer	0	40,614	100 % directly
A AKER CARBON CAPTURE ASA	NO0010890304	203,000	1,817,549,000	< 0.01 % directly
A AKER HORIZONS ASA	NO0010921232	0	10,524,000,000	< 0.01 % directly
A AUSTEVOLL SEAFOOD ASA	NO0010073489	2,586,000	4,619,656,000	< 0.01 % directly
A AF GRUPPEN ASA	NO0003078107	612,000,000	1,568,000,000	< 0.01 % directly
N NYKODE THERAPEUTICS ASA	NO0010714785	13,362,000	174,832,000	< 0.01 % directly
E EXACT THERAPEUTICS AS	NO0010852213	4,458	42,261,999	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024